Acupuncture Therapy in the Management of Orofacial Pain and Headaches: A Systematic Review and Meta-Analysis
Background: The patient’s quality of life may be impacted by pain and dysfunction ranging from moderate discomfort to severe agony. Objective: To evaluate the viability of acupuncture for managing orofacial pain and headaches through meta-analysis. Methodology: The review was conducted following “Pr...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Journal of Indian Academy of Oral Medicine and Radiology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jiaomr.jiaomr_188_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
The patient’s quality of life may be impacted by pain and dysfunction ranging from moderate discomfort to severe agony.
Objective:
To evaluate the viability of acupuncture for managing orofacial pain and headaches through meta-analysis.
Methodology:
The review was conducted following “Preferred Reporting Items for Systematic Review and Meta-Analysis” (PRISMA) 2020 and registered in PROSPERO-CRD42034561. Databases were searched for studies evaluating the effectiveness of acupuncture compared to conventional therapy for managing orofacial pain and headaches and their effect on pain reduction from June 1991 till April 2023. Revman software version 5.3 was used for quality assessment, while the Cochrane risk of bias (ROB)-2 tool was used for randomized controlled trials (RCT). Standardized mean difference (SMD) was summarized using a random effect model.
Results:
Moderate to low ROB was revealed on quality assessment. The pooled estimate favored acupuncture in reducing orofacial pain – SMD = 0.76 (−1.27–0.26), reducing headache with SMD is 0.11 (−0.34–0.12) compared to alternative therapies. Systematic heterogeneity was revealed on funnel plots indicating the presence of publication bias.
Conclusion:
Acupuncture is more effective in reducing orofacial pains and headaches. Further trials are needed to support the results of our study. |
|---|---|
| ISSN: | 0972-1363 0975-1572 |